Patents Assigned to Santhera Pharmaceuticals (Schweitz) AG
  • Patent number: 10806703
    Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: October 20, 2020
    Assignees: LTS Lohmann Therapie-System AG, Santhera Pharmaceuticals (Schweitz) AG
    Inventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann
  • Publication number: 20140377312
    Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.
    Type: Application
    Filed: January 17, 2013
    Publication date: December 25, 2014
    Applicant: Santhera Pharmaceuticals (Schweitz) AG
    Inventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann